正确操作：将HeartMate 3作为致心律失常性右室心肌病患者的终末期治疗右心室辅助装置
Do it "RIGHT": HeartMate 3 as Destination Therapy Right Ventricular Assist Device in a Patient With Arrhythmogenic Right Ventricular Cardiomyopathy.
作者信息
Hanuna Maja, Kääb Stefan, Hagl Christian, Mueller Christoph S
机构信息
From the Department of Cardiac Surgery, University Hospital, LMU Munich, Munich, Germany.
Department of Medicine I, University Hospital, LMU Munich, Munich, Germany.
出版信息
ASAIO J. 2023 Jan 1;69(1):e46-e48. doi: 10.1097/MAT.0000000000001746. Epub 2022 Apr 25.
Isolated right ventricular failure presents a rare pathology and heart transplantation remains the treatment of choice. Because of the shortage of donor organs, alternative treatment options are required. However, current continuous-flow ventricular assist devices are designed and approved only for left ventricular support and right ventricular implantation usually presents a procedure of last resort. Herein, we present a successful implantation of the HeartMate 3 for isolated right ventricular support as destination therapy in a patient suffering from late-onset arrhythmogenic right ventricular cardiomyopathy.
孤立性右心室衰竭是一种罕见的病理情况，心脏移植仍然是首选的治疗方法。由于供体器官短缺，需要其他治疗选择。然而，目前的连续血流心室辅助装置仅设计用于左心室支持，右心室植入通常是最后的手段。在此，我们报告了一例成功植入HeartMate 3用于孤立性右心室支持作为终末期治疗的病例，该患者患有迟发性致心律失常性右心室心肌病。
Zotero 插件